Significant Ownership of Bain Capital Life Sciences Fund II, L.P.

Signature - Title
/s/ Andrew Hack - Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bain Capital Life Sciences Fund II, L.P..

Notify me when Bain Capital Life Sciences Fund II, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Bain Capital Life Sciences Fund II, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SVRA Savara Inc. Common Stock, par value $0.001 per share 9.99% $56M 17.6M Bain Capital Life Sciences Fund II, L.P. Mar 25, 2025
CCCC C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.25% $13.5M 6.06M BCLS II Equity Opportunities, LP Oct 17, 2025
MRSN Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share 4% $1.54M 199K BCLS II Investco, LP Nov 12, 2025

Schedules 13D/G Reported by Bain Capital Life Sciences Fund II, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.